In the current study, beyond the recurrent founder c.211dupA mutation, a novel private BRCA1 mutation, c.2418dupA, was identified in a breast cancer patient from the North-East of Tunisia, using targeted gene sequencing. This evidence concerns the gene BRCA1 and breast cancer.